ACTINIUM PHARMACEUTICALS, INC. Proceeds from Debt, Net of Issuance Costs
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Proceeds from Debt, Net of Issuance Costs of $800.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromDebtNetOfIssuanceCosts · last filed 2023-03-31
- ACTINIUM PHARMACEUTICALS, INC. proceeds from debt, net of issuance costs for fiscal 2022 was $800.00K.
- ACTINIUM PHARMACEUTICALS, INC. proceeds from debt, net of issuance costs for fiscal 2011 was $645.89K.
| Period end | Proceeds from Debt, Net of Issuance Costs 12 month | Proceeds from Debt, Net of Issuance Costs 151 month | Proceeds from Debt, Net of Issuance Costs 154 month | Proceeds from Debt, Net of Issuance Costs 157 month | Proceeds from Debt, Net of Issuance Costs 160 month | Proceeds from Debt, Net of Issuance Costs 163 month | Proceeds from Debt, Net of Issuance Costs 166 month |
|---|---|---|---|---|---|---|---|
| 2022-12-31 | $800.00K 10-K · filed 2023-03-31 | ||||||
| 2014-03-31 | $645.89K 10-Q · filed 2014-05-12 | ||||||
| 2013-12-31 | $645.89K 10-K · filed 2014-02-28 | ||||||
| 2013-09-30 | $645.89K 10-Q · filed 2013-11-14 | ||||||
| 2013-06-30 | $645.89K 10-Q · filed 2013-08-13 | ||||||
| 2013-03-31 | $645.89K 10-Q · filed 2013-05-15 | ||||||
| 2012-12-31 | $645.89K 10-K · filed 2013-03-29 | ||||||
| 2011-12-31 | $645.89K 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |